Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
InspireMD logo — Embolic Protection that lasts CGuard MicroNet Carotid Stent...

InspireMD

Embolic Protection that lasts CGuard MicroNet Carotid Stent System

Founded 2005 86 employees Post Ipo Equity Total: $224.13M Biopharma, Biotechnology +2

General Information

Company Name InspireMD
Founded Year 2005
Founders / Decision Makers
Team member
Employees 86
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Post Ipo Equity
Social

Get notified when InspireMD moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About InspireMD

InspireMD is a commercial-stage medical device company specializing in proprietary and innovative stent designs with integrated embolic prevention systems (EPS) dedicated to delivering neurovascular protection and stroke prevention. The company's proprietary MicroNet™ technology is aimed at establishing its products as the industry standard for treating carotid artery disease, providing exceptional acute results and durable stroke-free long-term outcomes through its proprietary stent platform, CGuard™ EPS. This offering brings to the world the only carotid stent platform with patented MicroNet™ mesh technology, designed to reduce stroke during and after CAS. Founded in 2005, InspireMD is traded on NASDQ Capital Markets. The company recently secured a $113.60M post-IPO equity investment on 15 May 2023. The investment was led by prominent firms including OrbiMed, Marshall Wace, Nantahala Capital, Soleus Capital, Velan Capital, LifeSci Capital LLC, and Rosalind Capital Partners. As a player in the Biopharma, Biotechnology, and Health Care industries, InspireMD demonstrates promising potential in the field of medical devices and stroke prevention.

Taxonomy: stent technology, embolic protection, neurovascular protection, stroke prevention, carotid artery disease, interventional cardiology, vascular procedures, innovative technology, proprietary stent platform, MicroNet™ technology, CGuard™ EPS, stroke reduction, Nasdaq-listed company, commercial-stage medical device company

Funding Rounds & Investors (11)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 01 Jul 2024
Post-IPO Equity •••••• 7
Investor Investor Investor Investor Investor Investor
•••• •••• 		15 May 2023
Post-IPO Equity •••••• - 04 Feb 2021
Post-IPO Equity •••••• - 26 Jan 2017
Post-IPO Equity •••••• - 08 Jul 2016

View All 11 Funding Rounds

InspireMD Alternatives & Competitors

InspireMD vs
Silk Road Medical, Inc.
Silk Road Medical, Inc. United States

Brighter patient outcomes through brighter clinical thinking

Post Ipo Equity
419 employees
Health Care, Health and Wellness
Compare InspireMD vs Silk Road Medical, Inc.
InspireMD vs
MIVI Neuroscience, Inc
MIVI Neuroscience, Inc United States

The Next Generation of Neurointervention

Series B
18 employees
Health Care, Medical Devices
Compare InspireMD vs MIVI Neuroscience, Inc
InspireMD vs
MedRhythms, Inc.
MedRhythms, Inc. United States

Creating a world where everyone with neurologic injuries and diseases has access to the highest qual...

Series Unknown
51 employees
Biotechnology, Health Care
Compare InspireMD vs MedRhythms, Inc.

FAQ About InspireMD

Embolic Protection that lasts CGuard MicroNet Carotid Stent System
InspireMD was founded in 2005.
InspireMD operates in the following industries: Biopharma, Biotechnology, Health Care, Medical Devices.
InspireMD has approximately 86 employees.
InspireMD has completed 11 funding rounds, raising a total of $224.13M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to InspireMD include Silk Road Medical, Inc., MIVI Neuroscience, Inc, MedRhythms, Inc., Stemedica Cell Technologies, Inc, Op2Lysis. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
InspireMD and Silk Road Medical, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors InspireMD and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes